Short-Term Bullish Options Activity in Therapix Biosciences (TRPX) -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Barclays Starts TRONOX (TROX) at Overweight, Regulatory Risk Offset By Valuation and Potential Synergies
December 14, 2017 3:25 AM ESTBarclays initiates coverage on TRONOX (NYSE: TROX) with a Overweight rating and a price target of $25.00.
Analyst Duffy Fischer says the company is likely to be the largest TiO2 operators if the Cristal TiO2 acquisition is consummated and if TiO2 strength remains that... More
